Literature DB >> 8151803

Evolution of the human immunodeficiency virus type 2 envelope gene in preimmunized and persistently infected rhesus macaques.

M H Bäyon-Auboyer1, F D Boussin, G Vogt, R Le Grand, B Vaslin, I Nicol-Jourdain, D Dormont.   

Abstract

The V3 and V4 domains of human immunodeficiency virus type 2 (HIV-2) env genes from 14 rhesus macaques experimentally infected by HIV-2 SBL6669/H5 were sequenced. No variation was observed in viral sequences from sera and from uncultured peripheral blood mononuclear cells during primary infection. The first mutations were detected 17 months after infection; they mainly concerned the region between the V3 and V4 domains and not those domains themselves, which are known to be hypervariable, suggesting that variation of V3 is a late event of HIV infection.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8151803      PMCID: PMC236836     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  38 in total

1.  Repertoire of neutralizing human monoclonal antibodies specific for the V3 domain of HIV-1 gp120.

Authors:  M K Gorny; J Y Xu; S Karwowska; A Buchbinder; S Zolla-Pazner
Journal:  J Immunol       Date:  1993-01-15       Impact factor: 5.422

2.  Genetic variability of the AIDS virus: nucleotide sequence analysis of two isolates from African patients.

Authors:  M Alizon; S Wain-Hobson; L Montagnier; P Sonigo
Journal:  Cell       Date:  1986-07-04       Impact factor: 41.582

3.  Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction.

Authors:  P Chomczynski; N Sacchi
Journal:  Anal Biochem       Date:  1987-04       Impact factor: 3.365

4.  Possible involvement of HIV in neuropsychiatric episode in patient seronegative for two (or more) years.

Authors:  F Boussin; D Dormont; Y Merrouche; H Fleury; D Dubeaux; D Bequet; J Goasguen; P Brunet
Journal:  Lancet       Date:  1987-09-05       Impact factor: 79.321

5.  Molecular cloning and polymorphism of the human immune deficiency virus type 2.

Authors:  F Clavel; M Guyader; D Guétard; M Sallé; L Montagnier; M Alizon
Journal:  Nature       Date:  1986 Dec 18-31       Impact factor: 49.962

6.  HIV-2 in rhesus monkeys: serological, virological and clinical results.

Authors:  D Dormont; J Livartowski; S Chamaret; D Guetard; D Henin; R Levagueresse; P F van de Moortelle; B Larke; P Gourmelon; R Vazeux
Journal:  Intervirology       Date:  1989       Impact factor: 1.763

7.  Clinical and virological aspects of HIV2 infection in rhesus monkeys.

Authors:  J Livartowski; D Dormont; F Boussin; S Chamaret; D Guetard; R Vazeux; P Lebon; H Metivier; L Montagnier
Journal:  Cancer Detect Prev       Date:  1992

8.  Neutralization of diverse human immunodeficiency virus type 1 variants by an anti-V3 human monoclonal antibody.

Authors:  M K Gorny; A J Conley; S Karwowska; A Buchbinder; J Y Xu; E A Emini; S Koenig; S Zolla-Pazner
Journal:  J Virol       Date:  1992-12       Impact factor: 5.103

9.  Isolation of a T-lymphotropic retrovirus from a patient at risk for acquired immune deficiency syndrome (AIDS).

Authors:  F Barré-Sinoussi; J C Chermann; F Rey; M T Nugeyre; S Chamaret; J Gruest; C Dauguet; C Axler-Blin; F Vézinet-Brun; C Rouzioux; W Rozenbaum; L Montagnier
Journal:  Science       Date:  1983-05-20       Impact factor: 47.728

10.  Development of a quasispecies of human immunodeficiency virus type 1 in vivo.

Authors:  K Cichutek; H Merget; S Norley; R Linde; W Kreuz; M Gahr; R Kurth
Journal:  Proc Natl Acad Sci U S A       Date:  1992-08-15       Impact factor: 11.205

View more
  1 in total

1.  Genetic variation in a human immunodeficiency virus type 2 live-virus Macaca nemestrina vaccine model.

Authors:  A Radaelli; G Kraus; A Schmidt; P Badel; J McClure; S L Hu; W Morton; C De Giuli Morghen; F Wong-Staal; D Looney
Journal:  J Virol       Date:  1998-10       Impact factor: 5.103

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.